Freeze-dried plasma: From damage control resuscitation to coronavirus disease 2019 therapy.

Henry T PengShawn G RhindKaty MoesDana V DevineCraig JenkinsAndrew N Beckett

Published in: Transfusion (2022)

We demonstrated that FDP and CC-FDP retained the same hemostatic and antibody functional activities relative to their initial plasma sources, supporting clinical evaluation of their benefits in severe trauma and COVID-19 patients.

Keyphrases

coronavirus disease
cardiac arrest
sars cov
oxidative stress
early onset
drinking water
respiratory syndrome coronavirus
cardiopulmonary resuscitation
bone marrow
cell therapy